JPH0146520B2 - - Google Patents

Info

Publication number
JPH0146520B2
JPH0146520B2 JP51017432A JP1743276A JPH0146520B2 JP H0146520 B2 JPH0146520 B2 JP H0146520B2 JP 51017432 A JP51017432 A JP 51017432A JP 1743276 A JP1743276 A JP 1743276A JP H0146520 B2 JPH0146520 B2 JP H0146520B2
Authority
JP
Japan
Prior art keywords
astrocytin
malignin
tag
recognin
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP51017432A
Other languages
English (en)
Japanese (ja)
Other versions
JPS51108001A (de
Inventor
Bogochi Samyueru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPS51108001A publication Critical patent/JPS51108001A/ja
Publication of JPH0146520B2 publication Critical patent/JPH0146520B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4731—Recognins, e.g. malignin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57575—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
JP51017432A 1975-02-18 1976-02-18 Expired JPH0146520B2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55043275A 1975-02-18 1975-02-18
US55307575A 1975-02-25 1975-02-25
US62111275A 1975-10-09 1975-10-09

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP63130488A Division JPH01112163A (ja) 1975-02-18 1988-05-30 レコグニン類および関連物質

Publications (2)

Publication Number Publication Date
JPS51108001A JPS51108001A (de) 1976-09-25
JPH0146520B2 true JPH0146520B2 (de) 1989-10-09

Family

ID=27415588

Family Applications (2)

Application Number Title Priority Date Filing Date
JP51017432A Expired JPH0146520B2 (de) 1975-02-18 1976-02-18
JP63130488A Granted JPH01112163A (ja) 1975-02-18 1988-05-30 レコグニン類および関連物質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP63130488A Granted JPH01112163A (ja) 1975-02-18 1988-05-30 レコグニン類および関連物質

Country Status (4)

Country Link
JP (2) JPH0146520B2 (de)
CH (1) CH639102A5 (de)
DE (1) DE2606257A1 (de)
GB (1) GB1533464A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007214B1 (de) * 1978-07-07 1985-10-23 Samuel Dr. Bogoch Mittel zum Nachweis der Anwesenheit krebsartiger oder bösartiger Tumorzellen
GB2043890B (en) * 1979-01-30 1983-09-07 Otsuka Pharma Co Ltd Determination of tumour associated glycolinkage and diagnosis of cancer
ATE8897T1 (de) * 1979-03-09 1984-08-15 Samuel Dr. Bogoch Recognine, ihre chemoreziprokale, am target haftende globuline und verfahren zur herstellung dieser produkte; verfahren zum bestimmen von krebstumoren.

Also Published As

Publication number Publication date
CH639102A5 (en) 1983-10-31
DE2606257A1 (de) 1976-08-26
JPS51108001A (de) 1976-09-25
JPH0257671B2 (de) 1990-12-05
GB1533464A (en) 1978-11-22
JPH01112163A (ja) 1989-04-28

Similar Documents

Publication Publication Date Title
US4298590A (en) Detection of malignant tumor cells
Zabriskie et al. An immunological relationship between the group A streptococcus and mammalian muscle
Coons et al. Localization of antigen in tissue cells: II. Improvements in a method for the detection of antigen by means of fluorescent antibody
US4196186A (en) Method for diagnosing malignant gliol brain tumors
CA1215919A (en) Detection of malignant tumor cells
US4195017A (en) Malignin, derived from brain tumor cells, complexes and polypeptides thereof
Engelhardt et al. Localization of alpha‐fetoprotein in transplantable murine teratocarcinomas
JPS62181221A (ja) 免疫不全症候群治療用医薬組成物
US4624932A (en) Recognins and their chemoreciprocals
JPH0257671B2 (de)
EP0007214A1 (de) Mittel zum Nachweis der Anwesenheit krebsartiger oder bösartiger Tumorzellen
US4840915A (en) Method for diagnosing malignant tumors
JPH0124800B2 (de)
JPH0260983B2 (de)
JPH0321560B2 (de)
JPH0118080B2 (de)
US4624931A (en) Recognins and their chemoreciprocals
JPS6362517B2 (de)
US4976957A (en) Process for the production of recognins and their chemoreciprocals
CA1057684A (en) Recognins and their chemoreciprocals
JPH08511808A (ja) 多発性硬化症を伴う細胞毒性因子及びその検出並びにその定量
RU95111156A (ru) Способ диагностики злокачественных новообразований
Saurat et al. Pr antigens in the skin: distinct localization linked to the stage and the type of keratinocyte differentiation
FI92832C (fi) Yleinen syöpään liittyvä SCM-tunnistustekijä, menetelmä sen valmistamiseksi ja sen käyttö
Emmart et al. Studies on streptococcal hyaluronidase and antihyaluronidase. II. The localization of sites of absorption of streptococcal hyaluronidase (group C) with fluorescent antibody